The FDA assesses approval of a PTSD treatment combining talk therapy with MDMA, facing safety and efficacy concerns post-panel recommendation against approving the treatment.
Congress members advocate for FDA to consider the potential benefits of MDMA-assisted therapy, aligning with veterans and experts who support its sound science and call for broader access.
Prominent mental health experts and billionaires have also urged FDA for the approval of MDMA therapy, signaling a polarized debate around the potential treatment for PTSD.
Collection
[
|
...
]